<code id='65373DBE69'></code><style id='65373DBE69'></style>
    • <acronym id='65373DBE69'></acronym>
      <center id='65373DBE69'><center id='65373DBE69'><tfoot id='65373DBE69'></tfoot></center><abbr id='65373DBE69'><dir id='65373DBE69'><tfoot id='65373DBE69'></tfoot><noframes id='65373DBE69'>

    • <optgroup id='65373DBE69'><strike id='65373DBE69'><sup id='65373DBE69'></sup></strike><code id='65373DBE69'></code></optgroup>
        1. <b id='65373DBE69'><label id='65373DBE69'><select id='65373DBE69'><dt id='65373DBE69'><span id='65373DBE69'></span></dt></select></label></b><u id='65373DBE69'></u>
          <i id='65373DBE69'><strike id='65373DBE69'><tt id='65373DBE69'><pre id='65373DBE69'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:hotspot    Page View:55
          People waiting in line, standing in between red rope. -- first opinion coverage from STAT
          Adobe

          Health care providers and health insurance companies are closing the books on their third quarters, and one major question continues to hang over them: How much care is everyone actually getting, now that Covid-19 isn’t scaring so many away from doctors and hospitals?

          The short answer, according to financial analysts and the companies themselves: It appears people continue to fill prescriptions, see their doctors, and get recommended surgeries.

          advertisement

          For health insurers, those trends mean they will have to deposit more money into the bank accounts of providers — perhaps more than they predicted.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          The drug industry sees a key ally in the Senate prevail
          The drug industry sees a key ally in the Senate prevail

          NorthCarolinaSenatorRichardBurrreceivedstrongsupportfromthebiotechsector.GerryBroome/APWASHINGTON—Av

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          What the cancer research community can learn from the Covid response

          TinaReed,PaulKluetz,JohnOyler,andSolangePetersspeakattheMilkenInstituteFutureofHealthSummit.Screenca